Clark, New Jersey
United States
35
2018-12-13
The entities that hold a legal rights for patent applications filed by inventor Edmondson Scott D.:
Scott D. Edmondson from Clark, US has applied for patents for these inventions. The list has both pending applications and granted patents:
METHODS OF PREVENTING OR TREATING HYPOGLYCEMIA BY ADMINISTERING A GPR119 AGONIST
#2 | 2018-06-28Factor XIa inhibitors
#3 | 2018-01-04Factor XIa inhibitors
#4 | 2017-12-07BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
#5 | 2017-08-24Factor XIa inhibitors
#6 | 2017-08-24Factor XIa inhibitors
#7 | 2017-07-27Factor XIa inhibitors
#8 | 2017-07-13Factor Xla inhibitors
#9 | 2017-02-16Factor XIa inhibitors
#10 | 2016-12-29Factor XIa inhibitors
#11 | 2016-12-01Factor XIa inhibitors
#12 | 2016-11-24Factor XIa inhibitors
#13 | 2016-09-08Factor XIa Inhibitors
#14 | 2016-08-11Factor XIa Inhibitors
#15 | 2015-12-17BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
#16 | 2015-10-01SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT
#17 | 2014-10-23Pyrrolidine derived β3 adrenergic receptor agonists
#18 | 2014-05-08Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment
#19 | 2013-08-29Pyrrolidine derived β3 adrenergic receptor agonists
#20 | 2013-08-22BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
#21 | 2013-02-28β3 adrenergic receptor agonists
#22 | 2012-10-11Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
#23 | 2012-09-06Pyrrolidine derived beta 3 adrenergic receptor agonists
#24 | 2012-08-09COMBINATION THERAPY USING A BETA 3 ADRENERGIC RECEPTOR AGONISTS AND AN ANTIMUSCARINIC AGENT
#25 | 2012-06-21Pyrrolidine derived beta 3 adrenergic receptor agonists
#26 | 2012-03-01Pyrrolidine-derived beta 3 adrenergic receptor agonists
#27 | 2011-08-04Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes
#28 | 2011-02-03Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
#29 | 2011-02-03Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
#30 | 2009-10-15Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetes
#31 | 2009-10-08Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
#32 | 2009-09-17Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
#33 | 2008-03-27Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
#34 | 2008-01-241,2,4-Oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
#35 | 2008-01-10Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
116338 ⎘